The PennZone

  • Home
  • Business
  • Non-profit
  • Health
  • Technology
  • Entertainment
  • Real Estate
  • Music
  • Travel

Dr. Jeff Gelblum Provides Alzheimer's Treatment to Patients in the US and Abroad
The PennZone/10277342

Trending...
  • NOW OPEN - New Single Family Home Community in Manalapan
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
  • Kintetsu And Oversee Announce New Partnership
Alzheimer's Treatment
AVENTURA, Fla. - PennZone -- Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.

The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.

Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.

He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."

More on The PennZone
  • MITSUYA PLATING Expands ONE-STOP Service for US-based Medical Device, Semiconductor and Aerospace Manufacturers
  • Chester County Tile Expert Reveals Top Home Value Mistakes Homeowners Make During Remodeling Projects
  • Star Trek, Goonies, Ninja Turtles Stars Among First Main Wave Of FAN EXPO Philadelphia Celebrities
  • Voiset AI Planner Launches Smart Booking: Real Estate Agents, ADHD Coaches, Sales Teams End Calendar Chaos
  • Max Tucci Makes His Highly-Anticipated Debut On QVC—unveiling A Bespoke Luxury Chocolate Collection Inspired By 100 Years Of Tucci Hospitality

Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.

Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy.  This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."

For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.

His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.

Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.

More on The PennZone
  • Vehicledle Launches as Daily Puzzle Game for Car Enthusiasts
  • The Ms. Corporate America Maryland Competition Returns for an Unforgettable Evening of Leadership, Excellence, and Empowerment
  • Precision Adult Care Expands 24/7 Adult In-Home Care Services to Meet Growing Demand in the Coachella Valley
  • Metavalis Launches Massive Community Coat Drive in Branson to Support Local Residents
  • Jim Breuer is Coming to The Eichelberger Performing Arts Center This May

Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."

He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.

About Jeffrey Gelblum, MD, FAAN

Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/

Contact
First Choice Neurology
***@fcneurology.net


Source: First Choice Neurology

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Buildout Launches Native Email Marketing Feature, Expanding Its End-to-End CRE Platform
  • New Saxophone Prize Honors Astronaut Ronald E. McNair, First To Play Sax In Space
  • Building a $145M AI-Powered Marine Platform as Listings Surge, Global Expansion Begins, OTH Shares Trade at a Discount: Off The Hook YS (N Y S E: OTH)
  • American Disabilities Act Must Protect Against Forced Psychiatric Commitment and Treatment
  • 2025 Top Lawyers - ELA Awards by Expert Law Attorneys
  • Top Law Firms In 2025 - Expert Law Attorneys
  • Best Personal Injury Attorneys Of 2025 - ELA Awards
  • Best Personal Injury Law Firms 2025 - ELA Awards
  • Baruch Arcade Launches AI-Powered Gaming Platform on Solana, do I smell an airdrop?
  • Expert Law Attorneys 2025 Best Attorneys
  • Best Family Law Attorneys Of 2025 - ELA Awards
  • Best Criminal Defense Attorneys Of 2025 - ELA Awards
  • Americans Need $1.26 Million to Retire But Have Just $38K Saved — So They're Building Income Instead
  • Does EMDR Really Work? New Article Explores How Trauma Gets Stuck in the Brain and How Healing Begins
  • New Medium Article Explores Why Emotional Conversations Fail and What Most People Don't Understand About Connection
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
  • The Brave and the Rescued Honors LA Fire Department First Responders
  • Slick Cash Loan shares credit score tips for borrowers using bad credit loans
  • Crossroads4Hope Welcomes New Trustees to Board of Directors as Organization Enters 25th Year of Caring
  • PromptBuilder.cc Launches AI Prompt Generator Optimized For ChatGPT, Gemini, Grok & Claude

Popular on PennZone

  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board - 276
  • Mark Schork Selected As 'Board Observer' By Philadelphia Bar Foundation
  • IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever
  • Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
  • Lacy Hendricks Earns Prestigious MPM® Designation from NARPM®
  • Pawprint Oxygen Turns Pet Safety Viral With "Pets Live Here" Window Decals — Helping First Responders Save Lives
  • Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
  • RNHA Affirms Support for President Trump as Nation Marks Historic Victory for Freedom
  • The New Monaco of the South (of Italy)
  • Yunishigawa Onsen's Annual "Kamakura Festival" will be held January 30 – March 1, 2026

Similar on PennZone

  • MITSUYA PLATING Expands ONE-STOP Service for US-based Medical Device, Semiconductor and Aerospace Manufacturers
  • The Ms. Corporate America Maryland Competition Returns for an Unforgettable Evening of Leadership, Excellence, and Empowerment
  • Precision Adult Care Expands 24/7 Adult In-Home Care Services to Meet Growing Demand in the Coachella Valley
  • Metavalis Launches Massive Community Coat Drive in Branson to Support Local Residents
  • American Disabilities Act Must Protect Against Forced Psychiatric Commitment and Treatment
  • Does EMDR Really Work? New Article Explores How Trauma Gets Stuck in the Brain and How Healing Begins
  • New Medium Article Explores Why Emotional Conversations Fail and What Most People Don't Understand About Connection
  • Crossroads4Hope Welcomes New Trustees to Board of Directors as Organization Enters 25th Year of Caring
  • Impact Futures Group expands through acquisition of specialist healthcare sector training provider Caring for Care
  • Acuvance Acquires ROI Healthcare Solutions, Building a Dedicated Healthcare ERP Practice
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us